Economics deals with the allocation of scarce resources in a society with unlimited desires. When resources become scarce, people face difficult choices. This general concept holds true in the field of drug addiction treatment as well. Since drug use and its consequences are associated with...

Mindful of a number of issues, it looked as if the 54th CND would be an intriguing event. Held in Vienna between 21-25 March, the Commission would be the first for the new Executive Director of the United Nations Office on Drugs and Crime (UNODC), Mr. Yury Fedotov. It was also the first meeting...

Background: This paper analyses schemes to promote the authorisation of and reimbursement for orphan drugs. Methods: 8 countries - Australia, Canada, Germany, Great Britain, France, Netherlands, Switzerland, USA - were studied to compare specific regulations for orphan drugs regarding drug...

One of the barriers to drug policy analysis and reform is uncertainty as to the effects of possible policy changes (Shanahan & Ritter, 2012). This paper will use datafrom the Global Drug Survey to examine potential effects of policy changes in both the UK and Australian drug markets, based on...

In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supply reduction resulting from law enforcement...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts from the PDU network provide prevalence estimates of high-risk drug use by substance and the...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...

Injecting drugs is a key risk factor for contracting viral and other infections. Blood-borne infections acquired through the sharing of injecting equipment are among the most serious health harms of drug use. The drug-related infectious disease (DRID) indicator collects data on the extent of...

This evaluation assesses the degree of implementation of the EU Drugs Strategy 2013- 2020 and the Action Plan 2013-2016 in terms of outputs and, to the extent possible, impacts. It looks at the extent to which the objectives of the EU Drugs Strategy have been achieved, highlighting the areas...

In accordance with the Better Regulation guidelines a mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. The consultation was launched on 15 February 2016 on the...